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What is psycho-oncology?
Psycho-oncology is an evolving subspecialty 
generally focusing on psychological, social, 
behavioral and psychiatric aspects of oncol-
ogy. The science of psycho-oncology, which 
has developed particularly well over the past 
30 years, aims to provide an evidence base 
that could give direction to improvement of 
multidisciplinary cancer care by encompass-
ing and integrating mental healthcare and 
the psychological sciences.
Yet, psycho-oncology also includes a 
broader spectrum of interests and scientific 
activity; it encompasses an understanding 
of behavioral, social and lifestyle factors 
that contribute to increased risk of devel-
oping cancer. Furthermore, it provides 
insights into survivorship issues affecting 
people experiencing the late effects of cancer 
treatments and, in some cases, continuing 
physical and psychological disability. Until 
now, psycho-oncology has often struggled 
to become integrated with these aspects of 
cancer: a soft science that remained of low 
priority. What follows now are some specif-
ics on how it might be possible to better 
integrate psycho-oncology into cancer care.
Psycho-oncology in routine 
multidisciplinary cancer care
Areas that are providing improvements to 
patient quality of life include the introduc-
tion of routine assessment and screening 
for distress and coping. The International 
Psycho-Oncology Society [1] has advocated 
that screening for distress should be consid-
ered the sixth vital sign and incorporated 
into regular comprehensive cancer care [2]. 
Different methods of distress screening 
have been developed and evaluated to assist 
busy oncology staff in assessing patients’ 
psychosocial needs. The main impetus has 
been toward having professionals, directly 
involved in cancer care; make use of these 
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brief methods of distress screening on a regular 
basis.
In the UK, the NICE [3] has operationalized 
psychological care within a four-tier stepped care 
model. Patients with psychosocial care needs can 
be evaluated and treated using this approach 
moving from low through to high needs and 
level of care skills offered depend on further 
clinical assessment and triage.
In brief, stepped care models are where screen-
ing for distress or need is applied, and services 
targeted and delivered according to need. In this 
way care can be stepped up if distress or need fails 
to resolve. A related but different concept is that of 
low intensity care; an approach that has improved 
access as its central value [4]. Specifically, low 
intensity care aims to deliver evidence-based care 
in an equitable fashion and so utilizes novel deliv-
ery approaches (such as remote or nonspecialist 
delivery) to aid widespread dissemination. Several 
groups have operationalized these approaches in 
a range of settings. In one of the earliest mod-
els, and the first from a community setting, 
Hutchison and colleagues [5] proposed a tiered 
model that applied screening to identify patient 
need. Once identified, they triaged patients or 
carers to a level of care where the intensity of the 
intervention is matched to the depth of distress 
and the complexity of p resenting problem
Psychological intervention in cancer care: 
what works?
Delivery of psycho-oncology care at the lowest 
level of need can be provided by cancer clini-
cal staff with limited psychological skills train-
ing. A few studies have shown that nonpsy-
cho-oncologists can be trained to use specific 
formal psychological therapies, for example, 
cognitive–behavioral therapy (CBT) [6,7]. The 
minority of patients with more complex psycho-
social needs can be referred to psycho-oncolo-
gists, with advanced mental health skills, who 
will implement proven high-level therapies. 
Integrating these high level mental health spe-
cialists, into locations where cancer is treated, 
is essential to providing good seamless compre-
hensive care. Cancer patients should not have to 
attend external mental health units to receive this 
care, unless they have serious problems such as 
suicide risk requiring mental health management 
facilities. The amount of evidence on efficacy 
of psychological intervention for adult patients 
is substantial. There are a number of meta- 
analyses and supra-meta-analyses [8–13]. Newell 
and colleagues [10] provide one of the better 
reviews and conclude that group therapy, edu-
cation, counseling and CBT offer ‘most prom-
ise’ for medium- and long-term benefits. More 
recently the UK NICE [14,15] review of depression 
in adults with chronic health problems, recom-
mended the use of group CBT, individual CBT 
and computer-delivered CBT, as the treatments 
of choice for depression in patients with chronic 
health pr oblems, given the weight of evidence 
on efficacy.
How much does this all cost?
Increasingly healthcare providers are being 
asked to offer evidence of cost effectiveness 
to justify the introduction or continuation of 
healthcare services. To date, there has been a 
lack of data on cost–effectiveness in the field 
of psycho-oncology, although this is rapidly 
changing. Simpson and colleagues [16] found 
that in a randomized controlled study, a brief 
group psycho- educational intervention for breast 
cancer patients, when compared with a wait-list 
control group saved healthcare system costs. The 
evidence on cost effectiveness is slowly accumu-
lating [17–20]. Recently Dieng and colleagues [21] 
undertook a systematic review of psychosocial 
interventions in cancer, concluding that cog-
nitive–behavioral interventions in particular, 
represent good value for money in cancer care. 
However, several limitations in the literature 
were noted, including the need for more clarity 
in how economic questions are posed, a more 
comprehensive approach to measuring cost, and 
the need for further application of cost util-
ity measures to address the issue of estimating 
quality-adjusted life years. Economic analyses 
have been usefully applied to examine how care 
models or approaches can be used efficiently. 
As an example, Duarte et al. [22] examined the 
cost–effectiveness of collaborative treatment for 
cancer patients with depression and reported this 
approach was likely cost effective at the current 
thresholds used by NICE. This collaborative 
treatment model applied a multicomponent, 
manualized treatment program that integrates 
specialist depression treatment within oncology 
and primary care. The principal care deliverers 
in this approach are nurses, who work under 
the supervision of psychiatrists, with patients 
referred for psychiatric consultation if they fail 
to respond to treatment. In a community-based 
setting a trial with high distress cancer patients 
and carers found a single nurse counselor session 
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to be as effective as five psychologist delivered 
sessions of CBT [23]. However, an economic anal-
ysis by Chatterton et al. [24] found that for those 
patients and carers at the higher distress levels, 
the psychologist delivered intervention was likely 
more cost effective in terms of later health sector 
cost savings. What is clear from these studies 
is that the overall care framework is important 
in determining how efficiently overall resources 
are utilized.
Psycho-oncology & cancer prevention
A recent commentary [25] indicated that approxi-
mately 30% of cancer deaths are attributable to 
modifiable lifestyle, behavioral and psychosocial 
risk factors. With effective intervention these 
risk behaviors can be reduced and potentially 
half of all cancers prevented [26]. A recent edito-
rial highlights the role of social and cultural ine-
qualities in cancer outcomes and calls for more 
psychosocial research to be a future priority [27]. 
Psycho-oncology is not routinely included in ref-
erence to primary and secondary cancer preven-
tion and available behavioral interventions are 
not being fully utilized. The increasing focus 
on individual responsibilities to reduce cancer 
risk and the absent voice of psycho-oncology 
in cancer prevention, serves as an impetus for 
involvement of our discipline in creating and 
revising national cancer control plans.
Here is an agenda for change
There is still too little being done to integrate 
psycho- oncology into the spectrum of cancer 
control and care. A shift is needed, along with 
a willingness to see beyond the immediate pres-
sures to deal with cancer as a biological disease. 
We suggest, the following will provide a good 
structure for positive and productive change 
toward a  multidisciplinary comprehensive 
approach to cancer:
 ● Bring psychosocial, behavioral and psycho-
oncology scientists more firmly and directly 
into the national and global cancer prevention 
programs. There are still too few involved;
 ● Make psychosocial care of people with cancer 
a routinely accepted part of multidisciplinary 
cancer care: assess distress and support needs 
as the sixth vital sign;
 ● Change approaches to training in oncology. 
Psycho-oncologists have both highly specialist 
mental health skills to offer and a wonderful his-
tory of giving away their skills to other profes-
sionals. By offering training to improve psycho-
social care skills across the board, we can allow 
more patients to receive good psychosocial care;
 ● Ensure psycho-oncologists are integrated into 
cancer rehabilitation programs;
 ● Recognize that psycho-oncologists contribute 
in important ways to evidence based cancer 
care. Invite them into research committees; 
give them a role to play in the development of 
national and international policies on cancer 
care; increase their contribution to oncology 
training programs and multidisciplinary 
research;
 ● Support and encourage the development of 
psycho-oncology as a clinical science; by 
doing so you support an improvement in 
evidence-based care, and in the quality of life 
of those patients badly affected by cancer 
both p hysically and emotionally.
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